title: Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonist.
authors.affiliation: Department of Medicinal Biology, Pfizer Inc., Aichi, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Nagahisa
authors.forename: Y
authors.initials: Y
authors.lastname: Kanai
authors.forename: O
authors.initials: O
authors.lastname: Suga
authors.forename: K
authors.initials: K
authors.lastname: Taniguchi
authors.forename: M
authors.initials: M
authors.lastname: Tsuchiya
authors.forename: J A
authors.initials: JA
authors.lastname: Lowe
authors.forename: H J
authors.initials: HJ
authors.lastname: Hess
mesh_terms: D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005070:Evans Blue; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D017998:Leukotriene D4 / Q000494:pharmacology; D008297:Male; D015288:Neurokinin A / Q000494:pharmacology; D015287:Neurokinin B / Q000494:pharmacology; D064729:Neurokinin-1 Receptor Antagonists; D010972:Platelet Activating Factor / Q000494:pharmacology; D018040:Receptors, Neurokinin-1 / Q000502:physiology; D012867:Skin / Q000098:blood supply*; D013373:Substance P / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014513:Ureter / Q000187:drug effects / Q000502:physiology*
chemical_list: D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001713:Biphenyl Compounds; D064729:Neurokinin-1 Receptor Antagonists; D010972:Platelet Activating Factor; D018040:Receptors, Neurokinin-1; D013373:Substance P; D005070:Evans Blue; D017998:Leukotriene D4; D006632:Histamine; D015288:Neurokinin A; D015287:Neurokinin B; D001920:Bradykinin; C066892:CP 96345